U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
Girocovatein
INN  
Official Name English
316-533-Spike glycoprotein [533-glycine] (severe acute respiratory syndrome coronavirus 2 variant JN.1 precursor) fusion protein with 316-533-spike glycoprotein (severe acute respiratory syndrome coronavirus 2 variant JN.1 precursor)
Preferred Name English
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), omicron lineage JN.1 (Gisaid: EPI_ISL_18872762) spike (S) glycoprotein receptor binding domain (RBD) fragment (303-520, 1-218 in the current sequence), variant (K<sup>520</sup>>G<sup>218</sup>
Common Name English
girocovatein [INN]
Common Name English
Code System Code Type Description
FDA UNII
BAA4CV6ACY
Created by admin on Wed Apr 02 20:35:06 GMT 2025 , Edited by admin on Wed Apr 02 20:35:06 GMT 2025
PRIMARY
INN
13661
Created by admin on Wed Apr 02 20:35:06 GMT 2025 , Edited by admin on Wed Apr 02 20:35:06 GMT 2025
PRIMARY
CAS
3038651-03-2
Created by admin on Wed Apr 02 20:35:06 GMT 2025 , Edited by admin on Wed Apr 02 20:35:06 GMT 2025
PRIMARY
ACTIVE MOIETY
Girocovatein
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966